Ciproxifan maleate - CAS# 184025-19-2 osapride 9H-pyrido[1

9H-pyrido[1

It can cause the symptoms of diarrhoea and myelosuppression experienced by ~25% of the patients administered irinotecan

It is not approved for the clinical treatment of major depressive disorder in the USA

Smiles: CC(C)(C)[C@H](NC(=O)C1(CC1)C#N)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1C=CC(=CC=1)C1SC=NC=1C

1 fmole/nucleus of methylproamine is required to achieve a substantial level of radioprotection (DMF of 1

Ciproxifan maleate - CAS# 184025-19-2 osapride 9H-pyrido[1Ciproxifan, also known as FUB 359, is an extremely potent histamine H3 inverse agonist antagonist. Ciproxifan produces wakefulness and attentiveness in animal studies, and produced cognitive enhancing effects without prominent stimulant effects at relatively low levels of receptor occupancy, and pronounced wakefulness at higher doses. It has therefore been proposed as a potential treatment for sleep disorders such as narcolepsy and to improve